Clinical Trial Update: VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for VTS-270 in Niemann-Pick Disease Type C1 (NPC1) across Phase 2 and Phase 3, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• VTS-270 (2-hydroxypropyl-beta-cyclodextrin)

Snippet

Sponsor: Mandos LLC | Conditions: Niemann-Pick Disease, Type C | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-02-22